Berry J - Search Results

1

Safety and activity of anti-CD14 antibody IC14 (atibuclimab) in ALS: Experience with expanded access protocol.

Gelevski D, Addy G, Rohrer M, Cohen C, Roderick A, Winter A, Carey J, Scalia J, Yerton M, Weber H, Doyle M, Parikh N, Kane G, Ellrodt A, Burke K, D'Agostino D, Sinani E, Yu H, Sherman A, Agosti J, Redlich G, Charmley P, Crowe D, Appleby M, Ziegelaar B, Hanus K, Li Z, Babu S, Nicholson K, Luppino S, Berry J, Baecher-Allan C, Paganoni S, Cudkowicz M. Gelevski D, et al. Among authors: berry j. Muscle Nerve. 2023 May;67(5):354-362. doi: 10.1002/mus.27775. Epub 2022 Dec 30. Muscle Nerve. 2023. PMID: 36533976

2

New considerations in the design of clinical trials for amyotrophic lateral sclerosis.

Berry JD, Cudkowicz ME. Berry JD, et al. Clin Investig (Lond). 2011 Oct;1(10):1375-1389. doi: 10.4155/cli.11.127. Clin Investig (Lond). 2011. PMID: 22545191 Free PMC article.

3

The Combined Assessment of Function and Survival (CAFS): a new endpoint for ALS clinical trials.

Berry JD, Miller R, Moore DH, Cudkowicz ME, van den Berg LH, Kerr DA, Dong Y, Ingersoll EW, Archibald D. Berry JD, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2013 Apr;14(3):162-8. doi: 10.3109/21678421.2012.762930. Epub 2013 Jan 17. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 23323713 Review.

4

Predicting success: optimizing phase II ALS trials for the transition to phase III.

Berry JD, Cudkowicz ME, Shefner JM. Berry JD, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2014 Mar;15(1-2):1-8. doi: 10.3109/21678421.2013.838969. Amyotroph Lateral Scler Frontotemporal Degener. 2014. PMID: 24588460 Review.

5

Neuroprotective agents target molecular mechanisms of disease in ALS.

Zhu Y, Fotinos A, Mao LL, Atassi N, Zhou EW, Ahmad S, Guan Y, Berry JD, Cudkowicz ME, Wang X. Zhu Y, et al. Among authors: berry jd. Drug Discov Today. 2015 Jan;20(1):65-75. doi: 10.1016/j.drudis.2014.08.016. Epub 2014 Sep 6. Drug Discov Today. 2015. PMID: 25205348 Review.

6

Electrical impedance myography in the evaluation of the tongue musculature in amyotrophic lateral sclerosis.

Shellikeri S, Yunusova Y, Green JR, Pattee GL, Berry JD, Rutkove SB, Zinman L. Shellikeri S, et al. Muscle Nerve. 2015 Oct;52(4):584-91. doi: 10.1002/mus.24565. Epub 2015 Jun 3. Muscle Nerve. 2015. PMID: 25580728 Free PMC article.

7

Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?

Nicholson KA, Cudkowicz ME, Berry JD. Nicholson KA, et al. Neurotherapeutics. 2015 Apr;12(2):376-83. doi: 10.1007/s13311-015-0341-2. Neurotherapeutics. 2015. PMID: 25700798 Free PMC article. Review.

8

Preclinical Rodent Toxicity Studies for Long Term Use of Ceftriaxone.

Ratti E, Berry JD, Greenblatt DJ, Loci L, Ellrodt AS, Shefner JM, Cudkowicz ME. Ratti E, et al. Among authors: berry jd. Toxicol Rep. 2015;2:1396-1403. doi: 10.1016/j.toxrep.2015.09.010. Toxicol Rep. 2015. PMID: 26705515 Free PMC article.

9

Outcome measures in amyotrophic lateral sclerosis clinical trials.

Paganoni S, Cudkowicz M, Berry JD. Paganoni S, et al. Clin Investig (Lond). 2014;4(7):605-618. doi: 10.4155/cli.14.52. Clin Investig (Lond). 2014. PMID: 28203356 Free PMC article.

10

Developing multidisciplinary clinics for neuromuscular care and research.

Paganoni S, Nicholson K, Leigh F, Swoboda K, Chad D, Drake K, Haley K, Cudkowicz M, Berry JD. Paganoni S, et al. Muscle Nerve. 2017 Nov;56(5):848-858. doi: 10.1002/mus.25725. Epub 2017 Aug 29. Muscle Nerve. 2017. PMID: 28632945 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,728 results

Search Page